{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-064680","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.783789+00:00","generated_at":"2026-06-01T09:00:42.177669+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Novavax President of R&D Filip Dubovsky to retire effective June 30, 2024","bullets":["Dubovsky retires as President, R&D effective June 30, 2024.","Will provide consulting services for 12 months post-retirement at $15,000/month.","Company will pay COBRA premiums for up to 11 months.","Equity awards continue to vest during consulting period; unexercised options exercisable 90 days after.","Non-competition and non-solicitation covenants commence upon retirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-064680","json":"https://secwatch.observer/filing/0001104659-24-064680.json","markdown":"https://secwatch.observer/filing/0001104659-24-064680.md","text":"https://secwatch.observer/filing/0001104659-24-064680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924064680/0001104659-24-064680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924064680/tm2415419d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:00:42.177669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b89d27d43","claim":"Filip Dubovsky retired as President, Research and Development at NOVAVAX INC.","evidence_excerpt":"On May 20, 2024, Filip Dubovsky notified Novavax, Inc. (the “Company”) of his decision to retire as President, Research and Development, effective as of June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924064680/0001104659-24-064680-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"President, Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}